ELRIG and The Protein Society have announced the keynote speakers for the upcoming Protein Sciences in Drug Discovery 2026 conference, scheduled for November 10–11, 2026, at GSK Stevenage. The speakers include Prof Dame Carol Robinson, Dr Andrew Doré, and Prof Paula Booth.
This free-to-attend event will focus on emerging developments in protein science and their applications in drug discovery, including topics such as AI and machine learning, complex targets, biologic developability, and production challenges. Participants will have networking opportunities and a chance to present research for a poster award aimed at Early Career Professionals.
Keynote Speakers:
- Prof Dame Carol Robinson: A prominent figure in mass spectrometry, she will present insights on cell surface receptors and transporters.
- Dr Andrew Doré: Known for his work in structural biology and AI, he will discuss the future of drug discovery through Isomorphic Labs’ innovative approaches.
- Prof Paula Booth: She will highlight membrane protein folding in drug discovery, an often overlooked yet crucial aspect.
Del Trezise, Chair of ELRIG, emphasized the importance of this event in fostering scientific advancement and collaboration.
Dr Sam Barrell, President of The Protein Society, expressed enthusiasm for continuing the partnership with ELRIG to enhance collaboration in protein science.
Prof Booth also noted her eagerness to bring focus to the critical process of membrane protein folding in drug discovery discussions.
